TY - JOUR AU - Gringeri, A. AU - Mantovani, L. G. AU - Scalone, L. AU - Mannucci, P. M. AU - Grp, C. S. PY - 2003 DA - 2003// TI - Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2003-03-0941 DO - 10.1182/blood-2003-03-0941 ID - Gringeri2003 ER - TY - JOUR AU - Roth, D. A. AU - Tawa, N. E. AU - O’Brien, J. M. AU - Treco, D. A. AU - Selden, R. F. PY - 2001 DA - 2001// TI - Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200106073442301 DO - 10.1056/NEJM200106073442301 ID - Roth2001 ER - TY - JOUR AU - Powell, J. S. AU - Ragni, M. V. AU - White, G. C. PY - 2003 DA - 2003// TI - Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2003-01-0167 DO - 10.1182/blood-2003-01-0167 ID - Powell2003 ER - TY - JOUR AU - White, G. C. PY - 2001 DA - 2001// TI - Gene therapy in hemophilia: clinical trials update JO - Thromb Haemost VL - 86 ID - White2001 ER - TY - JOUR AU - Doering, C. B. AU - Gangadharan, B. AU - Dukart, H. Z. AU - Spencer, H. T. PY - 2007 DA - 2007// TI - Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity JO - Mol Ther VL - 15 ID - Doering2007 ER - TY - JOUR AU - Ide, L. M. AU - Gangadharan, B. AU - Chiang, K. Y. AU - Doering, C. B. AU - Spencer, H. T. PY - 2007 DA - 2007// TI - Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-04-082602 DO - 10.1182/blood-2007-04-082602 ID - Ide2007 ER - TY - JOUR AU - McCauslin, C. S. AU - Wine, J. AU - Cheng, L. PY - 2003 DA - 2003// TI - In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2002-12-3859 DO - 10.1182/blood-2002-12-3859 ID - McCauslin2003 ER - TY - JOUR AU - Worsham, D. N. AU - Schuesler, T. AU - Kalle, C. AU - Pan, D. PY - 2006 DA - 2006// TI - In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector JO - Mol Ther VL - 14 UR - https://doi.org/10.1016/j.ymthe.2006.05.014 DO - 10.1016/j.ymthe.2006.05.014 ID - Worsham2006 ER - TY - JOUR AU - Pan, D. AU - Gunther, R. AU - Duan, W. M. PY - 2002 DA - 2002// TI - Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow JO - Mol Ther VL - 6 UR - https://doi.org/10.1006/mthe.2002.0630 DO - 10.1006/mthe.2002.0630 ID - Pan2002 ER - TY - JOUR AU - Wang, X. AU - Shin, S. C. AU - Chiang, A. F. AU - Khan, I. AU - Pan, D. AU - Rawlings, D. J. AU - Miao, C. H. PY - 2015 DA - 2015// TI - Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2015.20 DO - 10.1038/mt.2015.20 ID - Wang2015 ER - TY - STD TI - Habi O, Girard J, Bourdages V, Delisle M-C, and Carreau M. Correction of Fanconi anemia group c hematopoietic stem cells following intrafemoral gene transfer. Anemia, 2010;2010. ID - ref11 ER - TY - JOUR AU - Baum, C. AU - Dullmann, J. AU - Li, Z. X. AU - Fehse, B. AU - Meyer, J. AU - Williams, D. A. AU - Kalle, C. PY - 2003 DA - 2003// TI - Side effects of retroviral gene transfer into hematopoietic stem cells JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-07-2314 DO - 10.1182/blood-2002-07-2314 ID - Baum2003 ER - TY - JOUR AU - Kaufman, R. J. AU - Powell, J. S. PY - 2013 DA - 2013// TI - Molecular approaches for improved clotting factors for hemophilia JO - Hematol Am Soc Hematol Educ Program VL - 2013 ID - Kaufman2013 ER - TY - JOUR AU - Gu, J. M. AU - Ramsey, P. AU - Evans, V. PY - 2014 DA - 2014// TI - Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94–9027) for haemophilia A JO - Haemophilia VL - 20 UR - https://doi.org/10.1111/hae.12374 DO - 10.1111/hae.12374 ID - Gu2014 ER - TY - JOUR AU - Mei, B. AU - Pan, C. AU - Jiang, H. PY - 2010 DA - 2010// TI - Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2009-11-254755 DO - 10.1182/blood-2009-11-254755 ID - Mei2010 ER - TY - JOUR AU - Nolan, B. AU - Mahlangu, J. AU - Perry, D. PY - 2016 DA - 2016// TI - Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A JO - Haemophilia VL - 22 UR - https://doi.org/10.1111/hae.12766 DO - 10.1111/hae.12766 ID - Nolan2016 ER - TY - JOUR AU - Schulte, S. PY - 2013 DA - 2013// TI - Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII JO - Thromb Res VL - 131 UR - https://doi.org/10.1016/S0049-3848(13)70150-6 DO - 10.1016/S0049-3848(13)70150-6 ID - Schulte2013 ER - TY - JOUR AU - Uchida, N. AU - Sambe, T. AU - Yoneyama, K. AU - Fukazawa, N. AU - Kawanishi, T. AU - Kobayashi, S. AU - Shima, M. PY - 2016 DA - 2016// TI - A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-06-650226 DO - 10.1182/blood-2015-06-650226 ID - Uchida2016 ER - TY - JOUR AU - Shima, M. AU - Hanabusa, H. AU - Taki, M. PY - 2016 DA - 2016// TI - Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1511769 DO - 10.1056/NEJMoa1511769 ID - Shima2016 ER - TY - JOUR AU - Monahan, P. E. PY - 2015 DA - 2015// TI - Gene therapy in an era of emerging treatment options for hemophilia B JO - J Thromb Haemost VL - 13 UR - https://doi.org/10.1111/jth.12957 DO - 10.1111/jth.12957 ID - Monahan2015 ER - TY - JOUR AU - Nathwani, A. C. AU - Reiss, U. M. AU - Tuddenham, E. G. PY - 2014 DA - 2014// TI - Long-term safety and efficacy of factor IX gene therapy in hemophilia B JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1407309 DO - 10.1056/NEJMoa1407309 ID - Nathwani2014 ER - TY - JOUR AU - Nathwani, A. C. AU - Tuddenham, E. G. D. AU - Rangarajan, S. PY - 2011 DA - 2011// TI - Adenovirus-associated virus vector-mediated gene transfer in hemophilia B JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1108046 DO - 10.1056/NEJMoa1108046 ID - Nathwani2011 ER - TY - JOUR AU - Callan, M. B. AU - Haskins, M. E. AU - Wang, P. AU - Zhou, S. AU - High, K. A. AU - Arruda, V. R. PY - 2016 DA - 2016// TI - Successful phenotype improvement following gene therapy for severe hemophilia a in privately owned dogs JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0151800 DO - 10.1371/journal.pone.0151800 ID - Callan2016 ER - TY - JOUR AU - McIntosh, J. AU - Lenting, P. J. AU - Rosales, C. PY - 2013 DA - 2013// TI - Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-10-462200 DO - 10.1182/blood-2012-10-462200 ID - McIntosh2013 ER - TY - JOUR AU - Siner, J. I. AU - Iacobelli, N. P. AU - Sabatino, D. E. PY - 2013 DA - 2013// TI - Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-10-464164 DO - 10.1182/blood-2012-10-464164 ID - Siner2013 ER - TY - STD TI - Adams B. BioMarin says hemophilia A gene therapy data ‘encouranging’. http://www.fiercebiotech.com/biotech/biomarin-says-hemophilia-a-gene-therapy-data-encouraging, 2016: April 20, 2016. UR - http://www.fiercebiotech.com/biotech/biomarin-says-hemophilia-a-gene-therapy-data-encouraging ID - ref26 ER - TY - JOUR AU - Zhou, S. AU - Mody, D. AU - DeRavin, S. S. PY - 2010 DA - 2010// TI - A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2009-10-250209 DO - 10.1182/blood-2009-10-250209 ID - Zhou2010 ER - TY - JOUR AU - Knight, S. AU - Bokhoven, M. AU - Collins, M. AU - Takeuchi, Y. PY - 2010 DA - 2010// TI - Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat JO - J Virol VL - 84 UR - https://doi.org/10.1128/JVI.02476-09 DO - 10.1128/JVI.02476-09 ID - Knight2010 ER - TY - JOUR AU - Aiuti, A. AU - Biasco, L. AU - Scaramuzza, S. PY - 2013 DA - 2013// TI - Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome JO - Science VL - 341 UR - https://doi.org/10.1126/science.1233151 DO - 10.1126/science.1233151 ID - Aiuti2013 ER - TY - JOUR AU - Biffi, A. AU - Montini, E. AU - Lorioli, L. PY - 2013 DA - 2013// TI - Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy JO - Science VL - 341 UR - https://doi.org/10.1126/science.1233158 DO - 10.1126/science.1233158 ID - Biffi2013 ER - TY - JOUR AU - Shi, Q. AU - Wilcox, D. A. AU - Fahs, S. A. PY - 2007 DA - 2007// TI - Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A JO - J Thromb Haemost VL - 5 UR - https://doi.org/10.1111/j.1538-7836.2007.02346.x DO - 10.1111/j.1538-7836.2007.02346.x ID - Shi2007 ER - TY - JOUR AU - Wang, C. X. AU - Sather, B. D. AU - Wang, X. PY - 2014 DA - 2014// TI - Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2013-12-546218 DO - 10.1182/blood-2013-12-546218 ID - Wang2014 ER - TY - JOUR AU - Kuether, E. AU - Schroeder, J. AU - Fahs, S. PY - 2012 DA - 2012// TI - Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing ant-factor VIII immunity JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2012.04791.x DO - 10.1111/j.1538-7836.2012.04791.x ID - Kuether2012 ER - TY - JOUR AU - Shi, Q. Z. AU - Wilcox, D. A. AU - Fahs, S. A. PY - 2006 DA - 2006// TI - Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies JO - J Clin Investig VL - 116 UR - https://doi.org/10.1172/JCI28416 DO - 10.1172/JCI28416 ID - Shi2006 ER - TY - JOUR AU - Yarovoi, H. V. AU - Kufrin, D. AU - Eslin, D. E. PY - 2003 DA - 2003// TI - Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2003-05-1519 DO - 10.1182/blood-2003-05-1519 ID - Yarovoi2003 ER - TY - JOUR AU - Damon, A. L. AU - Scudder, L. E. AU - Gnatenko, D. V. AU - Sitaraman, V. AU - Hearing, P. AU - Jesty, J. AU - Bahou, W. F. PY - 2008 DA - 2008// TI - Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice JO - Thromb Haemost VL - 100 ID - Damon2008 ER - TY - JOUR AU - Ohmori, T. AU - Mimuro, J. AU - Takano, K. PY - 2006 DA - 2006// TI - Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib alpha promoter: in vivo model for platelet-targeting gene therapy JO - FASEB J VL - 20 UR - https://doi.org/10.1096/fj.05-5161fje DO - 10.1096/fj.05-5161fje ID - Ohmori2006 ER - TY - JOUR AU - Neyman, M. AU - Gewirtz, J. AU - Poncz, M. PY - 2008 DA - 2008// TI - Analysis of the spatial and temporal characteristics of platelet-delivered factor VHI-based clots JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-04-152959 DO - 10.1182/blood-2008-04-152959 ID - Neyman2008 ER - TY - JOUR AU - Ward, N. J. AU - Buckley, S. M. AU - Waddington, S. N. PY - 2011 DA - 2011// TI - Codon optimization of human factor VIII cDNAs leads to high-level expression JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-05-282707 DO - 10.1182/blood-2010-05-282707 ID - Ward2011 ER - TY - JOUR AU - Scott, D. W. AU - Pratt, K. P. AU - Miao, C. H. PY - 2013 DA - 2013// TI - Progress toward inducing immunologic tolerance to factor VIII JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2013-01-478669 DO - 10.1182/blood-2013-01-478669 ID - Scott2013 ER - TY - JOUR AU - Matsui, H. AU - Shibata, M. AU - Brown, B. PY - 2009 DA - 2009// TI - A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3(+) T regulatory cells JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-03-202267 DO - 10.1182/blood-2009-03-202267 ID - Matsui2009 ER - TY - JOUR AU - Sack, B. K. AU - Merchant, S. AU - Markusic, D. M. AU - Nathwani, A. C. AU - Davidoff, A. M. AU - Byrne, B. J. AU - Herzog, R. W. PY - 2012 DA - 2012// TI - Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0037671 DO - 10.1371/journal.pone.0037671 ID - Sack2012 ER - TY - JOUR AU - Shi, Q. AU - Fahs, S. A. AU - Wilcox, D. A. PY - 2008 DA - 2008// TI - Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-02-138214 DO - 10.1182/blood-2008-02-138214 ID - Shi2008 ER - TY - JOUR AU - Brown, B. D. AU - Sitia, G. AU - Annoni, A. PY - 2007 DA - 2007// TI - In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-04-015537 DO - 10.1182/blood-2006-04-015537 ID - Brown2007 ER - TY - JOUR AU - Agudo, J. AU - Ruzo, A. AU - Kitur, K. AU - Sachidanandam, R. AU - Blander, J. M. AU - Brown, B. D. PY - 2012 DA - 2012// TI - A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade JO - Mol Ther VL - 20 UR - https://doi.org/10.1038/mt.2012.150 DO - 10.1038/mt.2012.150 ID - Agudo2012 ER - TY - JOUR AU - Akira, S. AU - Uematsu, S. AU - Takeuchi, O. PY - 2006 DA - 2006// TI - Pathogen recognition and innate immunity JO - Cell VL - 124 UR - https://doi.org/10.1016/j.cell.2006.02.015 DO - 10.1016/j.cell.2006.02.015 ID - Akira2006 ER - TY - BOOK AU - Wang, X. AU - Lyle, M. J. AU - Fu, R. AU - Miao, C. H. PY - 2015 DA - 2015// TI - Enhancing factor VIII expression in platelets of hemophilia A mice following intraosseous delivery of lentiviral vectors PB - American Society of Gene and Cell Therapy 18th Annual Meeting CY - New Orleans ID - Wang2015 ER -